Biomerics Welcomes Kristin Mason as New Chief Financial Officer to Elevate Financial Strategy
Biomerics, a frontrunner in the development and manufacturing of interventional medical devices, has officially appointed Kristin Mason as its new Chief Financial Officer. Announced on June 22, 2026, this strategic decision aligns with the company's vision to enhance its financial operations and support ongoing growth in a dynamic market.
Kristin Mason comes to Biomerics with a wealth of experience acquired over a distinguished career in finance, where she successfully led financial strategies within complex global organizations. In her new role, she will take over from a dedicated team of internal finance leaders, who have excelled in navigating the finance department through transformative periods over the last several months.
Arun Mohan, Biomerics' Chief Executive Officer, expressed enthusiasm regarding Mason's appointment, stating, "Kristin brings a unique blend of strategic financial leadership, operational rigor, and growth experience. Her comprehensive background in guiding organizations through mergers, acquisitions, and substantial growth positions her as the ideal leader for our next chapter at Biomerics."
Mason expressed her excitement about joining Biomerics, emphasizing the company’s dedication to improving lives through innovative medical technologies. "I am energized by this opportunity to lead Biomerics' financial operations. It’s thrilling to be part of a team so committed to enhancing patient outcomes with cutting-edge medical devices. I look forward to collaborating with our executive leadership to drive sustainable growth and production of our medical device components, subassemblies, and finished products."
In her capacity as CFO, Mason’s responsibilities will encompass comprehensive oversight of Biomerics' global finance organization. This includes critical areas such as financial planning and analysis, accounting, treasury, financial reporting, taxation, auditing, banking relations, and capital strategies. Her role will require close partnership with the executive leadership team to fortify financial operations, support the disciplined execution of strategic initiatives, and enable the company to sustain its trajectory of long-term expansion.
Founded in 1994, Biomerics has positioned itself as a key player within the interventional medical device manufacturing sector. The company is recognized for its integrated approach, combining engineering expertise with flexible manufacturing capabilities. Serving 20 of the top 30 medical device original equipment manufacturers (OEMs) globally, Biomerics offers a range of services including engineering design, technology transfer manufacturing, and various manufacturing services such as sterilization and packaging for medical devices.
With a notable presence across nine locations in the United States, in addition to facilities in Costa Rica and the Dominican Republic, Biomerics is well-equipped to cater to both immediate and long-term client needs. Their Centers of Excellence in engineering further sharpen their competitive edge in performance materials and technologies, such as interventional medical plastics, precision extrusion, and advanced catheter manufacturing.
Biomerics operates under stringent quality systems, ensuring compliance with international standards, including ISO certification and FDA regulations. As the company embarks on this new chapter with Kristin Mason at the financial helm, stakeholders eagerly await the innovative strategies she will implement to elevate Biomerics’ market position and operational excellence.
Kristin Mason comes to Biomerics with a wealth of experience acquired over a distinguished career in finance, where she successfully led financial strategies within complex global organizations. In her new role, she will take over from a dedicated team of internal finance leaders, who have excelled in navigating the finance department through transformative periods over the last several months.
Arun Mohan, Biomerics' Chief Executive Officer, expressed enthusiasm regarding Mason's appointment, stating, "Kristin brings a unique blend of strategic financial leadership, operational rigor, and growth experience. Her comprehensive background in guiding organizations through mergers, acquisitions, and substantial growth positions her as the ideal leader for our next chapter at Biomerics."
Mason expressed her excitement about joining Biomerics, emphasizing the company’s dedication to improving lives through innovative medical technologies. "I am energized by this opportunity to lead Biomerics' financial operations. It’s thrilling to be part of a team so committed to enhancing patient outcomes with cutting-edge medical devices. I look forward to collaborating with our executive leadership to drive sustainable growth and production of our medical device components, subassemblies, and finished products."
In her capacity as CFO, Mason’s responsibilities will encompass comprehensive oversight of Biomerics' global finance organization. This includes critical areas such as financial planning and analysis, accounting, treasury, financial reporting, taxation, auditing, banking relations, and capital strategies. Her role will require close partnership with the executive leadership team to fortify financial operations, support the disciplined execution of strategic initiatives, and enable the company to sustain its trajectory of long-term expansion.
Founded in 1994, Biomerics has positioned itself as a key player within the interventional medical device manufacturing sector. The company is recognized for its integrated approach, combining engineering expertise with flexible manufacturing capabilities. Serving 20 of the top 30 medical device original equipment manufacturers (OEMs) globally, Biomerics offers a range of services including engineering design, technology transfer manufacturing, and various manufacturing services such as sterilization and packaging for medical devices.
With a notable presence across nine locations in the United States, in addition to facilities in Costa Rica and the Dominican Republic, Biomerics is well-equipped to cater to both immediate and long-term client needs. Their Centers of Excellence in engineering further sharpen their competitive edge in performance materials and technologies, such as interventional medical plastics, precision extrusion, and advanced catheter manufacturing.
Biomerics operates under stringent quality systems, ensuring compliance with international standards, including ISO certification and FDA regulations. As the company embarks on this new chapter with Kristin Mason at the financial helm, stakeholders eagerly await the innovative strategies she will implement to elevate Biomerics’ market position and operational excellence.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.